Research News 2
-
Solving the Puzzle of Post-Treatment Control
New study reveals clues about post-treatment controllers—people who are able to control HIV after antiretrovirals are stopped.
-
Laying the Foundation for AIDS Research
40 years ago, Dr. Mathilde Krim co-founded AIDS Medical Foundation, the predecessor of amfAR, in order to propel AIDS research forward.
-
amfAR Cure Trial Shows Proof of Concept
Combination immunotherapy may induce virologic control after antiretroviral therapy is stopped, according to a new study that sheds light on curing HIV.
-
Groundbreaking amfAR Grantee Dr. Nancy Chang Honored
Baylor College of Medicine named a research symposium in honor of Dr. Nancy T. Chang and her pioneering work as a biochemist and businessperson
-
Women Making AIDS History
Women scientists and advocates, such as amfAR’s Dr. Mathilde Krim and Elizabeth Taylor, have been a driving force in the fight against AIDS.
-
Early Treatment No Barrier to Reservoir Formation
HIV too quickly creates pools of actively and latently infected T cells for antiretroviral therapy to block viral persistence.
-
Confirmed: Düsseldorf Patient Cured of HIV
Researchers have confirmed that a 53-year-old man in Germany named Marc, formerly known only as the Düsseldorf patient, has been cured of HIV via a stem cell transplant.
-
A Shared Passion for HIV Cure Research
In this interview, amfAR grantees Dr. Xu Yu and Dr. Mathias Lichterfeld, who are married, discuss their research interests and share their insights.
-
Footprints, Signatures, and Survival Factors
Aiming to identify HIV reservoirs, researchers use next-generation gene sequencing to detect markers on memory CD4 T cells.
-
The Road Ahead
HIV cure researchers convened a three-day workshop to share updates on HIV reservoirs and strategies aimed at achieving viral eradication.
-
How Do Some People Control HIV Without Antiretroviral Therapy?
Identifying mechanisms that allow elite controllers to suppress HIV in the absence of ART may aid in vaccine development.
-
Blocking T-Cell Growth: Will It Shrink the Reservoir?
A small cure trial explored the possibility that suppressing T-cell proliferation might reduce the HIV reservoir.
-
Dr. Lishomwa “Lish” Ndhlovu Takes the Lead
amfAR’s newly appointed Scientific Advisory Committee Chair discusses the power of collaboration and creating the space for unexpected breakthroughs in HIV cure research.
-
A Step Toward Eliminating Reservoir Cells?
Researchers identify markers on T cells with increased latent HIV in order to target them for elimination.
-
Meet the London Patient: Adam Castillejo
The second person cured of HIV talks to amfAR’s Dr. Rowena Johnston about advocacy and AIDS research..